Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

2Seventy Bio Inc (TSVT)

2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 234,921
  • Shares Outstanding, K 51,405
  • Annual Sales, $ 100,390 K
  • Annual Income, $ -217,570 K
  • 60-Month Beta 1.76
  • Price/Sales 2.24
  • Price/Cash Flow N/A
  • Price/Book 1.13
Trade TSVT with:

Options Overview Details

View History
  • Implied Volatility 137.62% ( +20.78%)
  • Historical Volatility 62.07%
  • IV Percentile 61%
  • IV Rank 37.54%
  • IV High 336.00% on 07/24/24
  • IV Low 18.37% on 10/19/23
  • Put/Call Vol Ratio 0.08
  • Today's Volume 708
  • Volume Avg (30-Day) 194
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 5,815
  • Open Int (30-Day) 5,311

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.83
  • Growth Rate Est. (year over year) +74.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.67 +30.34%
on 06/27/24
5.03 -4.87%
on 07/16/24
+1.19 (+33.06%)
since 06/26/24
3-Month
3.54 +35.31%
on 06/26/24
5.13 -6.63%
on 05/03/24
+0.53 (+12.57%)
since 04/26/24
52-Week
1.53 +212.05%
on 11/22/23
8.95 -46.48%
on 07/27/23
-4.67 (-49.37%)
since 07/26/23

Most Recent Stories

More News
2 Growth Stocks That Could Rocket Higher Before the End of 2023

Potential approvals of new medicines expected soon could push these stocks through the roof.

PFE : 30.77 (+3.39%)
ALNY : 234.84 (-1.28%)
TSVT : 4.79 (+4.81%)
BMY : 50.45 (+11.44%)
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress

2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy Company, today reported financial results and recent highlights for the first quarter ended March 31, 2023.

TSVT : 4.79 (+4.81%)
2seventy bio to Present New Preclinical and Clinical Data from Broad Portfolio of Investigational Cell Therapies at the ASGCT 26th Annual Meeting

2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced the presentation of five abstracts, including one late-breaking oral presentation, at this year’s American...

TSVT : 4.79 (+4.81%)
2seventy bio and Novo Nordisk Collaboration Delivers Key Proof of Concept Data, Triggering $15 Million Preclinical Milestone in In Vivo Gene Editing Hemophilia A Program

2seventy bio, Inc. (Nasdaq: TSVT) a leading immuno-oncology cell therapy company, today announced that it has achieved a preclinical $15 million milestone as part of the joint research and development...

TSVT : 4.79 (+4.81%)
2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023

2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023. 2seventy bio will host a conference...

TSVT : 4.79 (+4.81%)
Bristol Myers Squibb Reports First Quarter Financial Results for 2023

Bristol Myers Squibb (NYSE:BMY) today reports results for the first quarter of 2023, which reflect robust in-line and new product portfolio growth, strong commercial execution and continued advancement...

BMY : 50.45 (+11.44%)
TSVT : 4.79 (+4.81%)
Regulatory Applications Accepted Across Three Regions Globally for Abecma for Earlier Use in Adults with Triple-Class Exposed Relapsed and/or Refractory Multiple Myeloma

Bristol Myers Squibb (NYSE: BMY) and 2seventy bio, Inc. (Nasdaq: TSVT) today announced that the U.S. Food and Drug Administration (FDA) has accepted the companies’ supplemental Biologics License Application...

BMY : 50.45 (+11.44%)
TSVT : 4.79 (+4.81%)
2seventy bio Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Progress

2seventy bio, Inc . (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2022.

TSVT : 4.79 (+4.81%)
2seventy bio Announces Appointment of Wei Lin, M.D. to Board of Directors

2seventy bio, Inc. (Nasdaq: TSVT) today announced the appointment of Wei Lin, M.D. to the company’s Board of Directors, effective immediately.

TSVT : 4.79 (+4.81%)
2seventy bio to Participate in 43rd Annual TD Cowen Health Care Conference

2seventy bio, Inc . (Nasdaq: TSVT) announced today that members of the management team will present at the 43rd Annual TD Cowen Health Care Conference at the Boston Marriott Copley Place in Boston, MA...

TSVT : 4.79 (+4.81%)

Business Summary

2seventy bio Inc. is a cell and gene therapy company. It focuses on the research, development, and commercialization of treatments for cancer. 2seventy bio Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 5.19
2nd Resistance Point 5.01
1st Resistance Point 4.90
Last Price 4.79
1st Support Level 4.61
2nd Support Level 4.42
3rd Support Level 4.31

See More

52-Week High 8.95
Fibonacci 61.8% 6.12
Fibonacci 50% 5.24
Last Price 4.79
Fibonacci 38.2% 4.37
52-Week Low 1.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar